Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diabetic Foot: Treatment of Chronic Ulcers and Neuropathy With Transplantation of Placenta Derived Stem Cells (PDSC) - A Dose Escalation Safety and Exploratory Efficacy Study

NCT06373809 is registered in ClinicalTrials.gov with Michael H Carstens as lead sponsor.

NCT NCT06373809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06373809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diabetic Foot: Treatment of Chronic Ulcers and Neuropathy With Transplantation of Placenta Derived Stem Cells (PDSC) - A Dose Escalation Safety and Exploratory Efficacy Study
Lead sponsor
Michael H Carstens
Phase
Phase 1
Overall status
Completed
Start date
October 8, 2021
Completion date
March 31, 2024
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot, diabetic foot ulcer, diabetic neuropathies